{"pmid":32492123,"title":"The Importance of Advancing SARS-CoV-2 Vaccines in Children.","text":["The Importance of Advancing SARS-CoV-2 Vaccines in Children.","While the role of children in the chain of transmission of SARS-CoV-2 remains to be fully defined, they likely play an important role based on our knowledge of other respiratory viruses. Children are more likely to be asymptomatic or have milder symptoms and less likely to present for healthcare and be tested for SARS-CoV-2; thus, our current estimates are likely under-representative of the true burden of SARS-CoV-2 in children. Given the potential direct benefit of a SARS-CoV-2 vaccine in children and the substantial indirect benefit through community protection or 'herd immunity', we argue that planning and implementation of SARS-CoV-2 vaccines should include children. Furthermore, community protection occurred after widespread implementation of prior childhood vaccines against Streptococcus pneumoniae, rubella and rotavirus. We detail considerations for vaccine clinical trials, potential barriers to the implementation of widespread vaccination and argue why children would be an ideal target population for vaccination.","Clin Infect Dis","Kao, Carol M","Orenstein, Walter A","Anderson, Evan J","32492123"],"abstract":["While the role of children in the chain of transmission of SARS-CoV-2 remains to be fully defined, they likely play an important role based on our knowledge of other respiratory viruses. Children are more likely to be asymptomatic or have milder symptoms and less likely to present for healthcare and be tested for SARS-CoV-2; thus, our current estimates are likely under-representative of the true burden of SARS-CoV-2 in children. Given the potential direct benefit of a SARS-CoV-2 vaccine in children and the substantial indirect benefit through community protection or 'herd immunity', we argue that planning and implementation of SARS-CoV-2 vaccines should include children. Furthermore, community protection occurred after widespread implementation of prior childhood vaccines against Streptococcus pneumoniae, rubella and rotavirus. We detail considerations for vaccine clinical trials, potential barriers to the implementation of widespread vaccination and argue why children would be an ideal target population for vaccination."],"journal":"Clin Infect Dis","authors":["Kao, Carol M","Orenstein, Walter A","Anderson, Evan J"],"date":"2020-06-04T11:00:00Z","year":2020,"_id":"32492123","source":"PubMed","week":"202023|Jun 01 - Jun 07","doi":"10.1093/cid/ciaa712","keywords":["immunization","sars-cov-2","community protection","pediatrics"],"topics":["Treatment"],"weight":1,"_version_":1668623433654599681,"score":9.490897,"similar":[{"pmid":32382748,"title":"Lessons from COVID-19 in children: Key hypotheses to guide preventative and therapeutic strategies.","text":["Lessons from COVID-19 in children: Key hypotheses to guide preventative and therapeutic strategies.","The current pandemic of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative agent of coronavirus disease 2019 (COVID-19), reveals a peculiar trend of milder disease and lower case fatality in children compared to adults. Consistent epidemiologic evidence of reduced severity of infection in children across different populations and countries suggests there are underlying biologic differences between children and adults that mediate differential disease pathogenesis. This presents a unique opportunity to learn about disease modifying host factors from pediatric populations. Our review summarizes the current knowledge of pediatric clinical disease, role in transmission, risks for severe disease, protective immunity, as well as novel therapies and vaccine trials for children. We then define key hypotheses and areas for future research that can use the pediatric model of disease, transmission, and immunity to develop preventive and therapeutic strategies for people of all age groups.","Clin Infect Dis","Singh, Tulika","Heston, Sarah M","Langel, Stephanie N","Blasi, Maria","Hurst, Jillian H","Fouda, Genevieve G","Kelly, Matthew S","Permar, Sallie R","32382748"],"abstract":["The current pandemic of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative agent of coronavirus disease 2019 (COVID-19), reveals a peculiar trend of milder disease and lower case fatality in children compared to adults. Consistent epidemiologic evidence of reduced severity of infection in children across different populations and countries suggests there are underlying biologic differences between children and adults that mediate differential disease pathogenesis. This presents a unique opportunity to learn about disease modifying host factors from pediatric populations. Our review summarizes the current knowledge of pediatric clinical disease, role in transmission, risks for severe disease, protective immunity, as well as novel therapies and vaccine trials for children. We then define key hypotheses and areas for future research that can use the pediatric model of disease, transmission, and immunity to develop preventive and therapeutic strategies for people of all age groups."],"journal":"Clin Infect Dis","authors":["Singh, Tulika","Heston, Sarah M","Langel, Stephanie N","Blasi, Maria","Hurst, Jillian H","Fouda, Genevieve G","Kelly, Matthew S","Permar, Sallie R"],"date":"2020-05-09T11:00:00Z","year":2020,"_id":"32382748","source":"PubMed","week":"202019|May 04 - May 10","doi":"10.1093/cid/ciaa547","keywords":["covid-19","children","pediatrics","sars-cov-2","vaccines"],"topics":["Treatment","Prevention"],"weight":1,"_version_":1666267276777619456,"score":214.23146},{"pmid":32425304,"pmcid":"PMC7227545","title":"Reflection on lower rates of COVID-19 in children: does childhood immunizations offer unexpected protection?","text":["Reflection on lower rates of COVID-19 in children: does childhood immunizations offer unexpected protection?","The incidence of COVID-19 in children and teenagers is only about 2% in China. Children had mild symptoms and hardly infected other children or adults. It is worth considering that children are the most vulnerable to respiratory pathogens, but fatal SARS-like virus had not caused severe cases among them. According to the pathological studies of COVID-19 and SARS, a sharp decrease in T lymphocytes leads to the breakdown of the immune system. The cellular immune system of children differs from that of adults may be the keystone of atypical clinical manifestations or even covert infection. The frequent childhood vaccinations and repeated pathogens infections might be resulting in trained immunity of innate immune cells, immune fitness of adaptive immune cells or cross-protection of antibodies in the children. Therefore, due to lack of specific vaccine, some vaccines for tuberculosis, influenza and pneumonia may have certain application potential for the front-line health workers in the prevention and control of COVID-19. However, for high-risk susceptible populations, such as the elderly with basic diseases such as hypertension and diabetes, it is necessary to explore the acclimatization effect of the planned immune process on their immunity to achieve the trained immunity or immune fitness, so as to improve their own antiviral ability.","Med Hypotheses","Lyu, Jinglu","Miao, Tianyu","Dong, Jiajia","Cao, Ranran","Li, Yan","Chen, Qianming","32425304"],"abstract":["The incidence of COVID-19 in children and teenagers is only about 2% in China. Children had mild symptoms and hardly infected other children or adults. It is worth considering that children are the most vulnerable to respiratory pathogens, but fatal SARS-like virus had not caused severe cases among them. According to the pathological studies of COVID-19 and SARS, a sharp decrease in T lymphocytes leads to the breakdown of the immune system. The cellular immune system of children differs from that of adults may be the keystone of atypical clinical manifestations or even covert infection. The frequent childhood vaccinations and repeated pathogens infections might be resulting in trained immunity of innate immune cells, immune fitness of adaptive immune cells or cross-protection of antibodies in the children. Therefore, due to lack of specific vaccine, some vaccines for tuberculosis, influenza and pneumonia may have certain application potential for the front-line health workers in the prevention and control of COVID-19. However, for high-risk susceptible populations, such as the elderly with basic diseases such as hypertension and diabetes, it is necessary to explore the acclimatization effect of the planned immune process on their immunity to achieve the trained immunity or immune fitness, so as to improve their own antiviral ability."],"journal":"Med Hypotheses","authors":["Lyu, Jinglu","Miao, Tianyu","Dong, Jiajia","Cao, Ranran","Li, Yan","Chen, Qianming"],"date":"2020-05-20T11:00:00Z","year":2020,"_id":"32425304","source":"PubMed","week":"202021|May 18 - May 24","doi":"10.1016/j.mehy.2020.109842","keywords":["covid-19","childhood immunization","immune fitness","mild symptom in children","trained immunity"],"locations":["China","pneumonia"],"countries":["China"],"countries_codes":["CHN|China"],"topics":["Treatment","Mechanism"],"weight":1,"_version_":1667252837856313344,"score":185.22292},{"pmid":32470785,"title":"Reflection on lower rates of COVID-19 in children: Does childhood immunizations offer unexpected protection?","text":["Reflection on lower rates of COVID-19 in children: Does childhood immunizations offer unexpected protection?","The incidence of COVID-19 in children and teenagers is only about 2% in China. Children had mild symptoms and hardly infected other children or adults. It is worth considering that children are the most vulnerable to respiratory pathogens, but fatal SARS-like virus had not caused severe cases among them. According to the pathological studies of COVID-19 and SARS, a sharp decrease in T lymphocytes leads to the breakdown of the immune system. The cellular immune system of children differs from that of adults may be the keystone of atypical clinical manifestations or even covert infection. The frequent childhood vaccinations and repeated pathogens infections might be resulting in trained immunity of innate immune cells, immune fitness of adaptive immune cells or cross-protection of antibodies in the children. Therefore, due to lack of specific vaccine, some vaccines for tuberculosis, influenza and pneumonia may have certain application potential for the front-line health workers in the prevention and control of COVID-19. However, for high-risk susceptible populations, such as the elderly with basic diseases such as hypertension and diabetes, it is necessary to explore the remedial effect of the planned immune process on their immunity to achieve the trained immunity or immune fitness, so as to improve their own antiviral ability.","Med Hypotheses","Lyu, Jinglu","Miao, Tianyu","Dong, Jiajia","Cao, Ranran","Li, Yan","Chen, Qianming","32470785"],"abstract":["The incidence of COVID-19 in children and teenagers is only about 2% in China. Children had mild symptoms and hardly infected other children or adults. It is worth considering that children are the most vulnerable to respiratory pathogens, but fatal SARS-like virus had not caused severe cases among them. According to the pathological studies of COVID-19 and SARS, a sharp decrease in T lymphocytes leads to the breakdown of the immune system. The cellular immune system of children differs from that of adults may be the keystone of atypical clinical manifestations or even covert infection. The frequent childhood vaccinations and repeated pathogens infections might be resulting in trained immunity of innate immune cells, immune fitness of adaptive immune cells or cross-protection of antibodies in the children. Therefore, due to lack of specific vaccine, some vaccines for tuberculosis, influenza and pneumonia may have certain application potential for the front-line health workers in the prevention and control of COVID-19. However, for high-risk susceptible populations, such as the elderly with basic diseases such as hypertension and diabetes, it is necessary to explore the remedial effect of the planned immune process on their immunity to achieve the trained immunity or immune fitness, so as to improve their own antiviral ability."],"journal":"Med Hypotheses","authors":["Lyu, Jinglu","Miao, Tianyu","Dong, Jiajia","Cao, Ranran","Li, Yan","Chen, Qianming"],"date":"2020-05-30T11:00:00Z","year":2020,"_id":"32470785","source":"PubMed","week":"202022|May 25 - May 31","doi":"10.1016/j.mehy.2020.109842","keywords":["covid-19","childhood immunization","immune fitness","mild symptom in children","trained immunity"],"locations":["China","pneumonia"],"countries":["China"],"countries_codes":["CHN|China"],"topics":["Treatment","Mechanism"],"weight":1,"_version_":1668167109999329280,"score":185.22292},{"pmid":32377468,"pmcid":"PMC7198082","title":"First Case of an Infant with COVID-19 in the Middle East.","text":["First Case of an Infant with COVID-19 in the Middle East.","The novel coronavirus (COVID-19) has been declared a worldwide pandemic. It was initially thought to spare children and adolescents as significantly smaller number of cases have been reported in the pediatric population in comparison to adults. Here, we report the case of a 16-month-old female infant from Lebanon who presented with fever and severe diarrhea and tested positive for COVID-19. Her symptoms started six days prior to presentation with no cough, rhinorrhea, or other respiratory manifestations reported. Chest radiography showed lobar consolidation and bronchial infiltrates. Blood culture was positive for Streptococcus pneumoniae. Stool and urine cultures were negative. She was treated with ceftriaxone and metronidazole. Her RT-PCR test was negative after five days of treatment, suggesting that children can clear the virus faster than adults. The patient likely contracted the virus from her parents, who because of the fear of social stigma hide recent history of respiratory illness. These findings serve as a practical reference for the clinical diagnosis and medical treatment of children with COVID-19.","Cureus","Mansour, Amani","Atoui, Rola","Kanso, Kamal","Mohsen, Rami","Fares, Youssef","Fares, Jawad","32377468"],"abstract":["The novel coronavirus (COVID-19) has been declared a worldwide pandemic. It was initially thought to spare children and adolescents as significantly smaller number of cases have been reported in the pediatric population in comparison to adults. Here, we report the case of a 16-month-old female infant from Lebanon who presented with fever and severe diarrhea and tested positive for COVID-19. Her symptoms started six days prior to presentation with no cough, rhinorrhea, or other respiratory manifestations reported. Chest radiography showed lobar consolidation and bronchial infiltrates. Blood culture was positive for Streptococcus pneumoniae. Stool and urine cultures were negative. She was treated with ceftriaxone and metronidazole. Her RT-PCR test was negative after five days of treatment, suggesting that children can clear the virus faster than adults. The patient likely contracted the virus from her parents, who because of the fear of social stigma hide recent history of respiratory illness. These findings serve as a practical reference for the clinical diagnosis and medical treatment of children with COVID-19."],"journal":"Cureus","authors":["Mansour, Amani","Atoui, Rola","Kanso, Kamal","Mohsen, Rami","Fares, Youssef","Fares, Jawad"],"date":"2020-05-08T11:00:00Z","year":2020,"_id":"32377468","source":"PubMed","week":"202019|May 04 - May 10","doi":"10.7759/cureus.7520","keywords":["children","coronavirus","covid-19","gastrointestinal symptoms","infants","lebanon","middle east","pandemic","pediatrics","sars-cov-2"],"locations":["Lebanon"],"countries":["Lebanon"],"countries_codes":["LBN|Lebanon"],"e_drugs":["Metronidazole","Ceftriaxone"],"topics":["Case Report"],"weight":1,"_version_":1666596532360577024,"score":182.78462},{"pmid":32330332,"title":"SARS-CoV-2 infection in children - Understanding the immune responses and controlling the pandemic.","text":["SARS-CoV-2 infection in children - Understanding the immune responses and controlling the pandemic.","In December 2019, a cluster of patients with severe pneumonia caused by a novel coronavirus (SARS-CoV-2) emerged in the city of Wuhan, China. The disease is now termed coronavirus disease 2019 (COVID-19). In the early reports, the patients were mainly middle-aged and elderly men, and children appeared to be less susceptible to this infection. With modern and efficient transportation, the disease quickly spread to almost all corners of the world and the mortality far exceeds that caused by severe acute respiratory syndrome (SARS) coronavirus or Middle East respiratory syndrome (MERS) coronavirus. As the number of children with COVID-19 gradually increases, the disease has been documented in premature babies, infants, children, and adolescents. Severe and fatal cases in children are relatively rare. The burden of disease in children has been relatively low, but the high proportions of asymptomatic or mildly symptomatic infections in children deserve careful attention. A clear understanding of the immune responses to the virus in children and the transmission potential of asymptomatic children is of paramount importance for the development of specific treatments and vaccine in order to effectively control the ongoing pandemic.","Pediatr Allergy Immunol","Lu, Xiaoxia","Xiang, Yun","Du, Hui","Wing-Kin Wong, Gary","32330332"],"abstract":["In December 2019, a cluster of patients with severe pneumonia caused by a novel coronavirus (SARS-CoV-2) emerged in the city of Wuhan, China. The disease is now termed coronavirus disease 2019 (COVID-19). In the early reports, the patients were mainly middle-aged and elderly men, and children appeared to be less susceptible to this infection. With modern and efficient transportation, the disease quickly spread to almost all corners of the world and the mortality far exceeds that caused by severe acute respiratory syndrome (SARS) coronavirus or Middle East respiratory syndrome (MERS) coronavirus. As the number of children with COVID-19 gradually increases, the disease has been documented in premature babies, infants, children, and adolescents. Severe and fatal cases in children are relatively rare. The burden of disease in children has been relatively low, but the high proportions of asymptomatic or mildly symptomatic infections in children deserve careful attention. A clear understanding of the immune responses to the virus in children and the transmission potential of asymptomatic children is of paramount importance for the development of specific treatments and vaccine in order to effectively control the ongoing pandemic."],"journal":"Pediatr Allergy Immunol","authors":["Lu, Xiaoxia","Xiang, Yun","Du, Hui","Wing-Kin Wong, Gary"],"date":"2020-04-25T11:00:00Z","year":2020,"_id":"32330332","source":"PubMed","week":"202017|Apr 20 - Apr 26","doi":"10.1111/pai.13267","keywords":["sars-cov-2","children","coronavirus","immune response","pandemic"],"locations":["Wuhan","China"],"countries":["China"],"countries_codes":["CHN|China"],"topics":["Treatment","Transmission","Mechanism"],"weight":1,"_version_":1666138494555127808,"score":168.47774}]}